Dance Biopharm Lands $9,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=912033e5-a96b-46e1-b0d1-979d5a9521f9 - Date
2/19/2015 - Company Name
Dance Biopharm - Mailing Address
150 North Hill Drive Brisbane, CA 94005 USA - Company Description
Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide. The company began operations in 2010 led by Dr. John Patton, who has over 20 years of experience in the development of inhaled insulin. - Website
http://www.dancebiopharm.com - Transaction Type
Venture Equity - Transaction Amount
$9,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
The proceeds will be used to fund human clinical studies, manufacture drug and devices for clinical studies, and for working capital and general corporate purposes. - M&A Terms
- Venture Investor
